SecBot SecBot
PRESS-RELEASE ·Filed Apr 24, 2026

CATX

Perspective Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Traders should monitor the May 11 release of first-quarter financial results for material updates on cash burn, trial progress, or guidance. The May 4 analyst event may provide strategic clarity ahead of data readouts.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CATX ▼ -33.92% at T+60d
NEUTRAL call -33.92% · α vs SPY -39.00% · entry $4.51 → $2.98
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
-5.32%
call -5.32% · α -5.49%
$4.27
settled 6mo ago
T+5d
-13.53%
call -13.53% · α -14.43%
$3.90
settled 6mo ago
T+20d
-14.19%
call -14.19% · α -18.22%
$3.87
settled 5mo ago
T+60d
-33.92%
call -33.92% · α -39.00%
$2.98
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Perspective Therapeutics announced upcoming corporate updates in May 2026, including an analyst event, first-quarter financial results press release, and participation in two healthcare conferences. No financial results or material operational updates were released at this time.

Key Facts

  • Company will host an analyst event on May 4, 2026, covering strategy, technology, and pipeline.
  • First Quarter 2026 Financial Results to be released via press release only on May 11, 2026, after market close.
  • Company to participate in BofA Securities and RBC Capital Markets healthcare conferences on May 13 and May 19, 2026, respectively.
  • No financial data or material developments were disclosed in this announcement.

Financial Impact

No immediate financial impact — this is a scheduling announcement only.

Risk Factors

  • Forward-looking statements are subject to risks including clinical trial delays, funding shortfalls, and regulatory uncertainty.
  • Failure to meet upcoming clinical or operational milestones could negatively impact investor sentiment.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3280654
24 reports for CATX
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 3 of 5 best @ T+60▲ +5.76%Jun 12, 2026
Filters
Rows
Reports for CATX — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
8-K
BULLISH ★ 6/10
$1.61awaiting T+20—$1.19 (−26.09%)
Oct 8, 2026
19d ago
8-K
BULLISH ★ 6/10
$2.71awaiting T+20—$1.19 (−56.09%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 3/10
$2.76awaiting T+20—$1.19 (−56.88%)
Sep 14, 2026
6w ago
8-K
BULLISH ★ 5/10
$2.92 $2.52▼ −13.70%▼ −15.96%$1.19 (−59.25%)
Sep 11, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$2.81 $2.66▼ −5.34%▼ −7.21%$1.19 (−57.65%)
Sep 8, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.99 $2.46▼ −17.73%▼ −19.67%$1.19 (−60.20%)
Sep 4, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.12 $2.36▼ −24.36%▼ −26.07%$1.19 (−61.86%)
Sep 4, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.12 $2.36▼ −24.36%▼ −26.07%$1.19 (−61.86%)
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$3.18 $2.99▼ −5.97%▼ −4.92%$1.19 (−62.58%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$2.99 $3.20▲ +7.02%▲ +2.58%$1.19 (−60.20%)
Showing 10 of 24

US Market Status

Market Closed — Opens Thu (11h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026